Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pearlman

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Annals of Allergy|September 11, 1991
Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitisR A Nathan, E A Bronsky, P Fireman, et al.
Prehospital Emergency Care|January 4, 2018
Cincinnati Prehospital Stroke Scale Can Identify Large Vessel Occlusion StrokeChristopher T Richards, Ryan Huebinger, Katie L Tataris, et al.
Annals of Internal Medicine|January 22, 2000
Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study GroupJ M Edelman, J A Turpin, E A Bronsky, et al.
The Journal of Allergy and Clinical Immunology|December 10, 1999
A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholineJ P Kemp, A C DeGraff, D S Pearlman, et al.
Journal of Medicinal Chemistry|August 24, 2000
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptorsR E Wilcox, W H Huang, M Y Brusniak, et al.
Annals of Allergy|September 1, 1994
Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitisC H Banov, T R Woehler, C F LaForce, et al.
BMC Pulmonary Medicine|March 2, 2011
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthmaJoseph M Parker, Chad K Oh, Craig LaForce, et al.
The New England Journal of Medicine|November 12, 1992
A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthmaD S Pearlman, P Chervinsky, C LaForce, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1991
Intranasal fluocortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsyH A Orgel, E O Meltzer, C W Bierman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 2, 2000
Efficacy and safety of dry powder fluticasone propionate in children with persistent asthmaC F LaForce, D S Pearlman, M E Ruff, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Annals of Allergy|September 11, 1991
Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitisR A Nathan, E A Bronsky, P Fireman, et al.
Prehospital Emergency Care|January 4, 2018
Cincinnati Prehospital Stroke Scale Can Identify Large Vessel Occlusion StrokeChristopher T Richards, Ryan Huebinger, Katie L Tataris, et al.
Annals of Internal Medicine|January 22, 2000
Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study GroupJ M Edelman, J A Turpin, E A Bronsky, et al.
The Journal of Allergy and Clinical Immunology|December 10, 1999
A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholineJ P Kemp, A C DeGraff, D S Pearlman, et al.
Journal of Medicinal Chemistry|August 24, 2000
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptorsR E Wilcox, W H Huang, M Y Brusniak, et al.
Annals of Allergy|September 1, 1994
Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitisC H Banov, T R Woehler, C F LaForce, et al.
BMC Pulmonary Medicine|March 2, 2011
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthmaJoseph M Parker, Chad K Oh, Craig LaForce, et al.
The New England Journal of Medicine|November 12, 1992
A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthmaD S Pearlman, P Chervinsky, C LaForce, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1991
Intranasal fluocortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsyH A Orgel, E O Meltzer, C W Bierman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 2, 2000
Efficacy and safety of dry powder fluticasone propionate in children with persistent asthmaC F LaForce, D S Pearlman, M E Ruff, et al.
Pageof 17